1,200
Views
21
CrossRef citations to date
0
Altmetric
Review Article

Coeliac disease – from genetic and immunological studies to clinical applications

, , &
Pages 708-717 | Received 15 Mar 2015, Accepted 15 Mar 2015, Published online: 07 Apr 2015

References

  • WKDicke, HAWeijers, JHVan De Kamer. Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease. Acta Paediatr 1953;42:34–42.
  • LMSollid, KELundin. Celiac disease. In NRose, IMackay, editors. The autoimmune diseases. 5th ed. Elsevier; 2014. pp 855–71.
  • KELundin, LMSollid. Advances in coeliac disease. Curr Opin Gastroenterol 2014;30:154–62.
  • LMSollid, BJabri. Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol 2013;13:294–302.
  • JFLudvigsson, JCBai, FBiagi, TRCard, CCiacci, PJCiclitira, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut 2014;63:1210–28.
  • HHin, GBird, PFisher, NMahy, DJewell. Coeliac disease in primary care: case finding study. Bmj 1999;318:164–7.
  • PCollin, KKaukinen, MValimaki, JSalmi. Endocrinological disorders and celiac disease. Endocr Rev 2002;23:464–83.
  • AMHjelle, EApalset, PMielnik, JBollerslev, KELundin, GSTell. Celiac disease and risk of fracture in adults– review. Osteoporos Int 2014;25:1667–76.
  • KKaukinen, MPeraaho, PCollin, JPartanen, NWoolley, TKaartinen, et al. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. Scand J Gastroenterol 2005;40:564–72.
  • DALeffler, DSchuppan. Update on serologic testing in celiac disease. Am J Gastroenterol 2010;105:2520–4.
  • JCBai, MFried, GRCorazza, DSchuppan, MFarthing, CCatassi, et al. World Gastroenterology Organisation global guidelines on celiac disease. J Clin Gastroenterol 2013;47:121–6.
  • ARubio-Tapia, IDHill, CPKelly, AHCalderwood, JAMurray; American College of G. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013;108:656–76; quiz 77.
  • GOberhuber, GGranditsch, HVogelsang. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185–94.
  • KKurppa, PCollin, MViljamaa, KHaimila, PSaavalainen, JPartanen, et al. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology 2009;136:816–23.
  • KKurppa, APaavola, PCollin, HSievanen, KLaurila, HHuhtala, et al. Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease. Gastroenterology 2014;147:610–17; e1.
  • SHusby, SKoletzko, IRKorponay-Szabo, MLMearin, APhillips, RShamir, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54:136–60.
  • AIvarsson, AMyleus, FNorstrom, Mvan der Pals, ARosen, LHogberg, et al. Prevalence of childhood celiac disease and changes in infant feeding. Pediatrics 2013;131:e687–94.
  • AMyleus, AIvarsson, CWebb, LDanielsson, OHernell, LHogberg, et al. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 2009;49:170–6.
  • KStordal, IJBakken, PSuren, LCStene. Epidemiology of coeliac disease and comorbidity in Norwegian children. J Pediatr Gastroenterol Nutr 2013;57:467–71.
  • MMaki, KMustalahti, JKokkonen, PKulmala, MHaapalahti, TKarttunen, et al. Prevalence of Celiac disease among children in Finland. N Engl J Med 2003;348:2517–24.
  • SLohi, KMustalahti, KKaukinen, KLaurila, PCollin, HRissanen, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 2007;26:1217–25.
  • SDydensborg, PToftedal, MBiaggi, STLillevang, DGHansen, SHusby. Increasing prevalence of coeliac disease in Denmark: a linkage study combining national registries. Acta paediatr 2012;101:179–84.
  • AHorwitz, TSkaaby, LLKarhus, PSchwarz, TJorgensen, JJRumessen, et al. Screening for celiac disease in Danish adults. Scand J Gastroenterol 2015. [Epub ahead of print].
  • SLVriezinga, RAuricchio, EBravi, GCastillejo, AChmielewska, PCrespo Escobar, et al. Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med 2014;371:1304–15.
  • ELionetti, SCastellaneta, RFrancavilla, APulvirenti, ETonutti, SAmarri, et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med 2014;371:1295–303.
  • CAAronsson, HSLee, ELiu, UUusitalo, SHummel, JYang, et al. Age at gluten introduction and risk of celiac disease. Pediatrics 2015;135:239–45.
  • PLStokes, PAsquith, GKHolmes, PMackintosh, WTCooke. Histocompatibility antigens associated with adult coeliac disease. Lancet 1972;2:162–4.
  • BGSolheim, JEk, POThune, KBaklien, ABratlie, BRankin, et al. HLA antigens in dermatitis herpetiformis and coeliac disease. Tissue Antigens 1976;7:57–9.
  • GTrynka, KAHunt, NABockett, JRomanos, VMistry, ASzperl, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011;43:1193–201.
  • PCDubois, GTrynka, LFranke, KAHunt, JRomanos, ACurtotti, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010;42:295–302.
  • KAHunt, VMistry, NABockett, TAhmad, MBan, JNBarker, et al. Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature 2013;498:232–5.
  • VKumar, JGutierrez-Achury, KKanduri, RAlmeida, BHrdlickova, DVZhernakova, et al. Systematic annotation of celiac disease loci refines pathological pathways and suggests a genetic explanation for increased interferon-gamma levels. Hum Mol Genet 2015;24:397–409.
  • LMSollid, GMarkussen, JEk, HGjerde, FVartdal, EThorsby. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989;169:345–50.
  • VAbadie, LMSollid, LBBarreiro, BJabri. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 2011;29:493–525.
  • ASpurkland, LMSollid, IPolanco, FVartdal, EThorsby. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol 1992;35:188–92.
  • KKarell, ASLouka, SJMoodie, HAscher, FClot, LGreco, et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003;64:469–77.
  • TSHalstensen, HScott, OFausa, PBrandtzaeg. Gluten stimulation of coeliac mucosa in vitro induces activation (CD25) of lamina propria CD4+ T cells and macrophages but no crypt-cell hyperplasia. Scand J Immunol 1993;38:581–90.
  • KELundin, HScott, THansen, GPaulsen, TSHalstensen, OFausa, et al. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993;178:187–96.
  • KELundin, HScott, OFausa, EThorsby, LMSollid. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol 1994;41:285–91.
  • OMolberg, KKett, HScott, EThorsby, LMSollid, KELundin. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol 1997;46:103–9.
  • WVader, YKooy, PVan Veelen, ADe Ru, DHarris, WBenckhuijsen, et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 2002;122:1729–37.
  • Yvan de Wal, YMKooy, PAvan Veelen, SAPena, LMMearin, OMolberg, et al. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci USA 1998;95:10050–4.
  • ACamarca, RPAnderson, GMamone, OFierro, AFacchiano, SCostantini, et al. Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease. J immunology 2009;182:4158–66.
  • MBodd, MRaki, EBergseng, JJahnsen, KELundin, LMSollid. Direct cloning and tetramer staining to measure the frequency of intestinal gluten-reactive T cells in celiac disease. Eur J Immunol 2013;43:2605–12.
  • MBodd, CYKim, KELundin, LMSollid. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease. Gastroenterology 2012;142:552–61.
  • OMolberg, KELundin, EMNilsen, HScott, KKett, PBrandtzaeg, et al. HLA restriction patterns of gliadin- and astrovirus-specific CD4+ T cells isolated in parallel from the small intestine of celiac disease patients. Tissue Antigens 1998;52:407–15.
  • HAGjertsen, LMSollid, JEk, EThorsby, KELundin. T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand J Immunol 1994;39:567–74.
  • OMolberg, SNMcAdam, RKorner, HQuarsten, CKristiansen, LMadsen, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998;4:713–17.
  • CGianfrani, RTroncone, PMugione, ECosentini, MDe Pascale, CFaruolo, et al. Celiac disease association with CD8+ T cell responses: identification of a novel gliadin-derived HLA-A2-restricted epitope. J Immunol 2003;170:2719–26.
  • HWieser. Chemistry of gluten proteins. Food Microbiol 2007;24:115–19.
  • KELundin, LMSollid, DAnthonsen, ONoren, OMolberg, EThorsby, et al. Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease. Gastroenterology 1997;112:752–9.
  • HSjostrom, KELundin, OMolberg, RKorner, SNMcAdam, DAnthonsen, et al. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol 1998;48:111–15.
  • LMSollid, SWQiao, RPAnderson, CGianfrani, FKoning. Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics 2012;64:455–60.
  • HArentz-Hansen, RKorner, OMolberg, HQuarsten, WVader, YMKooy, et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000;191:603–12.
  • STollefsen, HArentz-Hansen, BFleckenstein, OMolberg, MRaki, WWKwok, et al. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest 2006;116:2226–36.
  • BFleckenstein, SWQiao, MRLarsen, GJung, PRoepstorff, LMSollid. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J Biol Chem 2004;279:17607–16.
  • MSiegel, PStrnad, REWatts, KChoi, BJabri, MBOmary, et al. Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS One 2008;3:e1861.
  • JStamnaes, DMPinkas, BFleckenstein, CKhosla, LMSollid. Redox regulation of transglutaminase 2 activity. J Biol Chem 2010;285:25402–9.
  • XJin, JStamnaes, CKlock, TRDiRaimondo, LMSollid, CKhosla. Activation of extracellular transglutaminase 2 by thioredoxin. J Biol Chem 2011;286:37866–73.
  • BLebwohl, PHGreen, JAMurray, JFLudvigsson. Season of birth in a nationwide cohort of coeliac disease patients. Arch Dis Child 2013;98:48–51.
  • LMSollid, OMolberg, SMcAdam, KELundin. Autoantibodies in coeliac disease: tissue transglutaminase – guilt by association? Gut 1997;41:851–2.
  • MMaki. editor. Sixth International Symposium on Coeliac Disease. Dublin, Ireland: Oak Tree Press; 1992.
  • SSulkanen, THalttunen, KLaurila, KLKolho, IRKorponay-Szabo, ASarnesto, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998;115:1322–8.
  • RDi Niro, LMesin, NYZheng, JStamnaes, MMorrissey, JHLee, et al. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med 2012;18:441–5.
  • OSteinsbo, CJHenry Dunand, MHuang, LMesin, MSalgado-Ferrer, KELundin, et al. Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells. Nat Commun 2014;5:4041.
  • RIversen, RDi Niro, JStamnaes, KELundin, PCWilson, LMSollid. Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells. J Immunol 2013;190:5981–91.
  • HQuarsten, SNMcAdam, TJensen, HArentz-Hansen, OMolberg, KELundin, et al. Staining of celiac disease-relevant T cells by peptide-DQ2 multimers. J Immunol 2001;167:4861–8.
  • RPAnderson, PDegano, AJGodkin, DPJewell, AVHill. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000;6:337–42.
  • RPAnderson, DAvan Heel, JATye-Din, MBarnardo, MSalio, DPJewell, et al. T cells in peripheral blood after gluten challenge in coeliac disease. Gut 2005;54:1217–23.
  • MRaki, LEFallang, MBrottveit, EBergseng, HQuarsten, KELundin, et al. Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients. Proc Natl Acad Sci USA 2007;104:2831–6.
  • MBrottveit, MRaki, EBergseng, LEFallang, BSimonsen, ALovik, et al. Assessing possible celiac disease by an HLA-DQ2-gliadin Tetramer Test. Am J Gastroenterol 2011;106:1318–24.
  • AChristophersen, MRaki, EBergseng, KELundin, JJahnsen, LMSollid, et al. Tetramer-visualized gluten-specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge. United European Gastroenterology J 2014;2:268–78.
  • SWQiao, MRaki, KSGunnarsen, GALoset, KELundin, ISandlie, et al. Posttranslational modification of gluten shapes TCR usage in celiac disease. J Immunol 2011;187:3064–71.
  • SEBroughton, JPetersen, ATheodossis, SWScally, KLLoh, AThompson, et al. Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease. Immunity 2012;37:611–21.
  • JPetersen, VMontserrat, JRMujico, KLLoh, DXBeringer, Mvan Lummel, et al. T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac disease. Nat Struct Mol Biol 2014;21:480–8.
  • PRGibson, SJShepherd. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol 2010;25:252–8.
  • JFLudvigsson, DALeffler, JCBai, FBiagi, AFasano, PHGreen, et al. The Oslo definitions for coeliac disease and related terms. Gut 2013;62:43–52.
  • KELundin, AAlaedini. Non-celiac gluten sensitivity. Gastrointest Endosc Clin N Am 2012;22:723–34.
  • UVolta, FTovoli, RCicola, CParisi, AFabbri, MPiscaglia, et al. Serological tests in gluten sensitivity (nonceliac gluten intolerance). J Clin Gastroenterol 2012;46:680–5.
  • ASapone, KMLammers, VCasolaro, MCammarota, MTGiuliano, MDe Rosa, et al. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Med 2011;9:23.
  • MBrottveit, ACBeitnes, STollefsen, JEBratlie, FLJahnsen, FEJohansen, et al. Mucosal cytokine response after short-term gluten challenge in celiac disease and non-celiac gluten sensitivity. Am J Gastroenterol 2013;108:842–50.
  • UVolta, MTBardella, ACalabro, RTroncone, GRCorazza; Study Group for Non-Celiac Gluten S. An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med 2014;12:85.
  • MBrottveit, POVandvik, SWojniusz, ALovik, KELundin, BBoye. Absence of somatization in non-coeliac gluten sensitivity. Scand J Gastroenterol 2012;47:770–7.
  • TAKabbani, RRVanga, DALeffler, JVillafuerte-Galvez, KPallav, JHansen, et al. Celiac disease or non-celiac gluten sensitivity? An approach to clinical differential diagnosis. Am J Gastroenterol 2014;109:741–6; quiz 7.
  • YJunker, SZeissig, SJKim, DBarisani, HWieser, DALeffler, et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med 2012;209:2395–408.
  • JRBiesiekierski, SLPeters, EDNewnham, ORosella, JGMuir, PRGibson. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013;145:320–8; e1-3.
  • LMSollid, BALie. Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol 2005;3:843–51.
  • WDieterich, TEhnis, MBauer, PDonner, UVolta, EORiecken, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797–801.
  • EKJanatuinen, PHPikkarainen, TAKemppainen, VMKosma, RMJarvinen, MIUusitupa, et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995;333:1033–7.
  • EKJanatuinen, TAKemppainen, RJJulkunen, VMKosma, MMaki, MHeikkinen, et al. No harm from five year ingestion of oats in coeliac disease. Gut 2002;50:332–5.
  • LHogberg, PLaurin, KFalth-Magnusson, CGrant, EGrodzinsky, GJansson, et al. Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut 2004;53:649–54.
  • KELundin, EMNilsen, HGScott, EMLoberg, AGjoen, JBratlie, et al. Oats induced villous atrophy in coeliac disease. Gut 2003;52:1649–52.
  • VGuttormsen, ALovik, ABye, JBratlie, LMorkrid, KELundin. No induction of anti-avenin IgA by oats in adult, diet-treated coeliac disease. Scand J Gastroenterol 2008;43:161–5.
  • HArentz-Hansen, BFleckenstein, OMolberg, HScott, FKoning, GJung, et al. The molecular basis for oat intolerance in patients with celiac disease. PLoS Med 2004;1:e1.
  • DTapsas, KFalth-Magnusson, LHogberg, TForslund, TSundqvist, EHollen. Urinary nitric oxide metabolites in children with celiac disease after long-term consumption of oats-containing gluten-free diet. Scand J Gastroenterol 2014;49:1311–17.
  • LShan, OMolberg, IParrot, FHausch, FFiliz, GMGray, et al. Structural basis for gluten intolerance in celiac sprue. Science 2002;297:2275–9.
  • LMSollid, CKhosla. Novel therapies for coeliac disease. J Intern Med 2011;269:604–13.
  • MLLahdeaho, KKaukinen, KLaurila, PVuotikka, OPKoivurova, TKarja-Lahdensuu, et al. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease. Gastroenterology 2014;146:1649–58.
  • RPAnderson, BJabri. Vaccine against autoimmune disease: antigen-specific immunotherapy. Curr Opin Immunol 2013;25:410–17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.